Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (171-180 of 435) with videos related to

Pageof 44
Sort By:
Arthritis Care & Research|September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trialVibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2020
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseasesWilliam Damsky, Danielle Peterson, Julie Ramseier, et al.
The Journal of Rheumatology|April 1, 2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritisVibeke Strand, David L Scott, Paul Emery, et al.
RMD Open|July 3, 2020
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world studyP G Conaghan, Rieke Alten, Atul Deodhar, et al.
Arthritis Research & Therapy|December 4, 2019
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugsVibeke Strand, Michael Schiff, Namita Tundia, et al.
Clinical and Experimental Rheumatology|August 28, 2018
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 studyAtul Deodhar, Philip G Conaghan, Tore K Kvien, et al.
The Lancet. Rheumatology|January 30, 2024
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumabVibeke Strand, Sean O'Quinn, Richard A Furie, et al.
The Journal of Rheumatology|March 17, 2019
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease ScaleLaure Gossec, Vibeke Strand, Clare Proudfoot, et al.
BMC Rheumatology|March 20, 2019
Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritisVibeke Strand, M Elaine Husni, Keith A Betts, et al.
Clinical Rheumatology|April 16, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trialsVibeke Strand, Eun Bong Lee, Yusuf Yazici, et al.
Pageof 44

Showing results (171-180 of 435) with videos related to

Sort By:
Pageof 44
Arthritis Care & Research|September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trialVibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2020
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseasesWilliam Damsky, Danielle Peterson, Julie Ramseier, et al.
The Journal of Rheumatology|April 1, 2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritisVibeke Strand, David L Scott, Paul Emery, et al.
RMD Open|July 3, 2020
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world studyP G Conaghan, Rieke Alten, Atul Deodhar, et al.
Arthritis Research & Therapy|December 4, 2019
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugsVibeke Strand, Michael Schiff, Namita Tundia, et al.
Clinical and Experimental Rheumatology|August 28, 2018
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 studyAtul Deodhar, Philip G Conaghan, Tore K Kvien, et al.
The Lancet. Rheumatology|January 30, 2024
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumabVibeke Strand, Sean O'Quinn, Richard A Furie, et al.
The Journal of Rheumatology|March 17, 2019
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease ScaleLaure Gossec, Vibeke Strand, Clare Proudfoot, et al.
BMC Rheumatology|March 20, 2019
Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritisVibeke Strand, M Elaine Husni, Keith A Betts, et al.
Clinical Rheumatology|April 16, 2018
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trialsVibeke Strand, Eun Bong Lee, Yusuf Yazici, et al.
Pageof 44